Clinical Trial Update: Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating adjuvant paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma; current status is not repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Esophageal Cancer | Phase 3 | Status: UNKNOWN